AU3825995A - Blocking expression of virulence factors in s. aureus - Google Patents

Blocking expression of virulence factors in s. aureus

Info

Publication number
AU3825995A
AU3825995A AU38259/95A AU3825995A AU3825995A AU 3825995 A AU3825995 A AU 3825995A AU 38259/95 A AU38259/95 A AU 38259/95A AU 3825995 A AU3825995 A AU 3825995A AU 3825995 A AU3825995 A AU 3825995A
Authority
AU
Australia
Prior art keywords
aureus
virulence factors
blocking expression
blocking
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38259/95A
Inventor
Naomi Balaban
Guangyong Ji
Richard P Novick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University NYU
Original Assignee
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York University NYU filed Critical New York University NYU
Publication of AU3825995A publication Critical patent/AU3825995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU38259/95A 1994-10-04 1995-10-02 Blocking expression of virulence factors in s. aureus Abandoned AU3825995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31849994A 1994-10-04 1994-10-04
US318499 1994-10-04
PCT/US1995/012708 WO1996010579A1 (en) 1994-10-04 1995-10-02 Blocking expression of virulence factors in s. aureus

Publications (1)

Publication Number Publication Date
AU3825995A true AU3825995A (en) 1996-04-26

Family

ID=23238434

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38259/95A Abandoned AU3825995A (en) 1994-10-04 1995-10-02 Blocking expression of virulence factors in s. aureus

Country Status (2)

Country Link
AU (1) AU3825995A (en)
WO (1) WO1996010579A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6447786B1 (en) 1994-10-04 2002-09-10 New York University Blocking expression of virulence factors in S. aureus
AU5939996A (en) * 1995-06-07 1996-12-30 Microcide Pharmaceuticals, Inc. Methods for evaluation of antimicrobial targets
US6020121A (en) * 1995-09-29 2000-02-01 Microcide Pharmaceuticals, Inc. Inhibitors of regulatory pathways
ATE290548T1 (en) * 1996-05-22 2005-03-15 Univ New York EXPRESSION BLOCKING OF VIRULENT FACTORS IN S. AUREUS
US6455323B1 (en) 1997-07-03 2002-09-24 Pharmacia & Upjohn Company Anti-bacterial methods and materials
GB9724859D0 (en) * 1997-11-26 1998-01-21 Univ Nottingham Compounds and their use as antibacterial agents
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections
US7323179B2 (en) 1997-12-19 2008-01-29 Naomi Balaban Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
US7534857B2 (en) 1997-12-19 2009-05-19 Centegen, Inc. Methods and compositions for the treatment and prevention of staphylococcal infections
EP1862549A3 (en) 1998-09-15 2008-02-13 Naomi Balaban Target of RNAIII activating protein (TRAP)
US6747129B1 (en) 1998-09-15 2004-06-08 The Regents Of The University Of California Target of RNAIII activating protein(TRAP)
EP1188831B1 (en) * 1998-09-15 2007-12-05 Naomi Balaban Target of RNAIII activating protein (TRAP)
EP1261362A2 (en) * 2000-02-10 2002-12-04 Intermune, Inc. Novel amino acid and peptide inhibitors of staphylococcus virulence
US6764823B2 (en) 2000-04-06 2004-07-20 Pharmacia & Upjohn Company Antimicrobial methods and materials
US7824691B2 (en) 2005-04-04 2010-11-02 Centegen, Inc. Use of RIP in treating staphylococcus aureus infections

Also Published As

Publication number Publication date
WO1996010579A1 (en) 1996-04-11

Similar Documents

Publication Publication Date Title
PH31158A (en) Cosmetic composition.
AU7392591A (en) Photochromic compound, composition and use thereof
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
ZA968250B (en) Cosmetic composition.
AU6514196A (en) Heterocyclic compounds, their preparation and use
ZA964711B (en) Novel compounds, the preparation and use thereof.
ZA964433B (en) Cosmetic composition.
AU2681895A (en) 8-aryl-1,6-naphthyridin-5-ones
ZA956877B (en) Cosmetic composition.
AU9075591A (en) N-halochitosans, their preparation and uses
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU1106195A (en) Heterocyclic compounds, their preparation and use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU6845994A (en) Solid protector against uv, process for its preparation and use thereof
AU644245B2 (en) Hair treatment composition
AU3825995A (en) Blocking expression of virulence factors in s. aureus
AU4267396A (en) Modified cannula
AU4069395A (en) Optically active benzothiepin derivative, its preparation and use
AU6514296A (en) Heterocyclic compounds, their preparation and use
AU7095296A (en) Phosphorylamides, their preparation and use
AU2637095A (en) Antimicrobial glove
EP0612513A3 (en) External skin treatment composition.
AU4278593A (en) Antimicrobial compositions, process for preparing the same and use
AU5922694A (en) 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
AU1441195A (en) Phenylmethyl hexanamides, and the use thereof